Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia.

ClinicalTrials.gov ID: NCT02107092

Public ClinicalTrials.gov record NCT02107092. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-label Extension to Study ZS-004 [Phase 3 Multicenter, Multi-phase, Multi-dose, Prospective, Randomized, Double-blind, Placebo-controlled Maintenance Study of Safety Efficacy of ZS (Sodium Zirconium Cycolsilicate) in Hyperkalemia.]

Study identification

NCT ID
NCT02107092
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
ZS Pharma, Inc.
Industry
Enrollment
123 participants

Conditions and interventions

Conditions

Interventions

  • Sodium Zirconium Cyclosilicate Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 30, 2014
Primary completion
Jul 30, 2015
Completion
Aug 30, 2015
Last update posted
Aug 14, 2018

2014 – 2015

United States locations

U.S. sites
41
U.S. states
17
U.S. cities
38
Facility City State ZIP Site status
Not listed Anniston Alabama 36207
Not listed Huntsville Alabama 35801
Not listed Scottsboro Alabama 35768
Not listed Phoenix Arizona 85027
Not listed Tempe Arizona 85284
Not listed Hawaiian Gardens California 90716
Not listed Los Angeles California 90022
Not listed Paramount California 90723
Not listed Riverside California 92505
Not listed Atlantis Florida 33462
Not listed Bradenton Florida 34208
Not listed Brandon Florida 33511
Not listed Brooksville Florida 34601
Not listed DeLand Florida 32720
Not listed Edgewater Florida 32132
Not listed Miami Florida 33015
Not listed Miami Florida 33125
Not listed Miami Lakes Florida 33014
Not listed Miami Lakes Florida 33018
Not listed New Smyrna Beach Florida 32168
Not listed Ocala Florida 34471
Not listed Summerfield Florida 34491
Not listed Tampa Florida 33607
Not listed Tampa Florida 33614
Not listed Winter Park Florida 32789
Not listed Columbus Georgia 31901
Not listed Decatur Georgia 30030
Not listed Evergreen Park Illinois 60805
Not listed Joliet Illinois 60435
Not listed Shreveport Louisiana 71101
Not listed Auburn Maine 04210
Not listed Chesterfield Michigan 48047
Not listed Kansas City Missouri 64411
Not listed Las Vegas Nevada 89115
Not listed Flushing New York 11355
Not listed Altoona Pennsylvania 16602
Not listed Providence Rhode Island 02903
Not listed Orangeburg South Carolina 29118
Not listed Sumter South Carolina 29150
Not listed Chattanooga Tennessee 37408
Not listed San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02107092, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 14, 2018 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02107092 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →